CacheBy

Echelon Inc 제품 카탈로그

총 3,575개 제품 중 1,201–1,300번째 · 13 / 36 쪽. 파트넘버 순입니다. 제품을 열면 사양과 함께 재고·가격·납기를 문의할 수 있습니다.

  1. 863-70 5MG5 mg (863-70)
  2. 863-72Ac-Val-Lys-Met-Asp-AFC (Caspase Substrate)
  3. 863-72 25MG25 mg (863-72 25mg)
  4. 863-72 5MG5 mg (863-72)
  5. 863-74Ac-Val-Glu-His-Asp-AFC (Caspase Substrate)
  6. 863-74 25MG25 mg (863-74 25mg)
  7. 863-74 5MG5 mg (863-74)
  8. 864-12Ac-Val-Ala-Asp-CHO (Caspase 1 (ICE) Inhibitor)
  9. 864-12 5MG5 mg (864-12 5mg)
  10. 864-15Ac-YVAD-CHO, Caspase 1 (ICE) Inhibitor
  11. 864-15 5MG5 mg (864-15)
  12. 864-20Ac-DEVD-CHO, Caspase 3 (Apopain) Inhibitor
  13. 864-20 5MG5 mg (864-20 5mg)
  14. 864-22Ac-Glu-Ser-Met-Asp-CHO (Procaspase 3 Inhibitor)
  15. 864-22 5MG5 mg (864-22)
  16. 864-29Cell Permeable Caspase 3 Inhibitor
  17. 864-29 0.5MG0.5 mg (864-29)
  18. 864-29 1MG1 mg (864-29)
  19. 864-38Cell Permeable Caspase 1 Inhibitor
  20. 864-38 0.5MG0.5 mg (864-38)
  21. 864-38 1MG1 mg (864-38)
  22. 864-42Ac-Leu-Glu-Val-Asp-CHO (Caspase 4 (ICH-2) Inhibitor)
  23. 864-42 5MG5 mg (864-42)
  24. 864-44Ac-Leu-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor)
  25. 864-44 5MG5 mg (864-44 5mg)
  26. 864-45Ac-Leu-Glu-His-Asp-CHO (Caspase 9 Inhibitor)
  27. 864-45 5MG5 mg (864-45 5mg)
  28. 864-46Ac-Val-Asp-Val-Ala-Asp-CHO (Caspase 2 (ICH-1) Inhibitor)
  29. 864-46 5MG5 mg (864-46 5mg)
  30. 864-65Ac-Ala-Glu-Val-Asp-CHO (Caspase 3 Inhibitor)
  31. 864-65 5MG5 mg (864-65 5mg)
  32. 864-85Ac-Leu-Glu-Glu-Asp-CHO (Caspase 13 Inhibitor)
  33. 864-85 5MG5 mg (864-85)
  34. 865-10Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH (MMP-2 / MMP-9 Substrate)
  35. 865-10 5MG5 mg (865-10)
  36. 865-21Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)-OH (Caspase 1 Substrate)
  37. 865-21 1MG1 mg (865-21)
  38. 865-30Ac-Ile-Glu-Pro-Asp-pNA (Granzyme B Substrate)
  39. 865-30 25MG25 mg (865-30)
  40. 865-30 5MG5 mg (865-30)
  41. 866-10Mca-Val-Asp-Val-Ala-Asp-Gly-Trp-Lys(DNP)-NH2 (Caspase 2 (ICH-1) Substrate )
  42. 866-10 25MG25 mg (866-10)
  43. 866-10 5MG5 mg (866-10)
  44. 866-12Ac-Ile-Gln-Ala-Cys-Arg-Gly-OH (Caspase Active Site Peptide)
  45. 866-12 5MG5 mg (866-12)
  46. 866-23Cathepsin L Inhibitor (RKLLW-NH2)
  47. 866-23 5MG5 mg (866-23)
  48. 866-25PKA Substrate
  49. 866-25 25MG25 mg (866-25)
  50. 866-25 5MG5 mg (866-25)
  51. 866-27Z-Arg-Arg-pNA (Cathepsin B substrate)
  52. 866-27 10MG10 mg (866-27)
  53. 866-27 25MG25 mg (866-27)
  54. 866-28Z-Phe-Tyr-CHO (Cathepsin L Inhibitor)
  55. 866-28 5MG5 mg (866-28 5mg)
  56. 866-29Z-Ala-Arg-Arg-MbNA (Cathepsin B Substrate II)
  57. 866-29 10MG10 mg (866-29 10mg)
  58. 866-30Z-Arg-Arg-AMC (Cathepsin B substrate)
  59. 866-30 10MG10 mg (866-30 10mg)
  60. 866-30 25MG25 mg (866-30 25mg)
  61. 866-31Z-Arg-Arg-MbNA (Cathepsin B Substrate)
  62. 866-31 10MG10 mg (866-31)
  63. 866-31 25MG25 mg (866-31)
  64. 866-39Ac-Leu-Val-Lys-CHO (Cathepsin B Inhibitor II)
  65. 866-39 1MG1 mg (866-39)
  66. 866-39 5MG5 mg (866-39 5mg)
  67. 866-75Z-Phe-Arg-AFC (Cathepsin L Substrate)
  68. 866-75 10MG10 mg (866-75 10mg)
  69. 866-761-Naphthalenesulfonyl-Ile-Trp-CHO (Cathepsin L Inhibitor)
  70. 866-76 1MG1 mg (866-76 1mg)
  71. 866-76 5MG5 mg (866-76 5mg)
  72. 866-80Cathepsin S Substrate, fluorogenic
  73. 866-80 1MG1 mg (866-80)
  74. 867-10PKA Inhibitor
  75. 867-10 1MG1 mg (867-10 1mg)
  76. 867-10 5MG5 mg (867-10)
  77. 868-10NFF-3 (MMP-3 Substrate)
  78. 868-10 1MG1 mg (868-10)
  79. 868-15Akt Substrate
  80. 868-15 25MG25 mg (868-15)
  81. 868-15 5MG5 mg (868-15)
  82. 868-20MCA-Pro-Leu-Ala-Nva-Dap(DNP)-Ala-Arg-NH2 (MMP-2 Substrate)
  83. 868-20 1MG1 mg (868-20)
  84. 868-20 5MG5 mg (868-20)
  85. 868-22MCA-Pro-Leu-Gly-Leu-Dap(DNP)-Ala-Arg-NH2 (MMP Substrate)
  86. 868-22 1MG1 mg (868-22)
  87. 868-22 5MG5 mg (868-22)
  88. 868-25MCA-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(DNP)-NH2 (MMP Substrate)
  89. 868-25 1MG1 mg (868-25)
  90. 868-25 5MG5 mg (868-25)
  91. 868-30MCA-Pro-Cha-Gly-Nva-His-Ala-Dap(DNP)-NH2 (MMP-13 Substrate)
  92. 868-30 1MG1 mg (868-30)
  93. 868-41MCA-Lys-Pro-Leu-Gly-Leu-Dap(DNP)-Ala-Arg-NH2 (MMP Substrate)
  94. 868-41 1MG1 mg (868-41)
  95. 868-42MCA-Pro-Leu-Ala-Cys(p-MeOBz)-Trp-Ala-Arg-Dap(DNP)-NH2 (MMP-11, MMP-14 substrate)
  96. 868-42 1MG1 mg (868-42)
  97. 868-42 5MG5 mg (868-42 5mg)
  98. 868-44Dnp-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-OH (MMP-8 Substrate)
  99. 868-44 25MG25 mg (868-44)
  100. 868-44 5MG5 mg (868-44)